Skip to Main Content
CWRU Links

Funding Resources

Recently Announced Funding Opportunities

Department of Defense

  • Idea Development Award 
    [LOI: Jul 13; Application: Oct 5]
  • Era of Hope Scholar Award 
    [LOI: Jun 8; Application: Jun 15]
  • Innovator Award 
    [LOI: Jun 9; Application: Aug 31]
  • Breakthrough Award Levels 1 and 2 
    [LOI: Jun 8; Application: Jun 15]
  • Breakthrough Award Levels 3 and 4 
    [LOI: Jun 8; Application: Jun 15]
  • Distinguished Investigator Award 
    [
    LOI: Jun 9; Application: Aug 31]
  • Breakthrough Fellowship Award 
    [
    LOI: Jun 8; Application: Jun 15]
  • Concept Award 
    [LOI: Jul 22; Application: Aug 10]
  • Career Development Award 
    [LOI: Sep 13; Application: Sep 27]
  • Idea Development Award 
    [LOI: Jun 28; Application: Sep 27]
  • Investigator Initiated Translational Research Award
    [LOI: Jun 28; Application: Sep 27]
  • Translational Research Partnership Award
    [LOI: Jun 28; Application: Sep 27]
  • Clinical Development Award 
    [LOI: Jun 21; Application: Sep 6]
  • Investigator-Initiated Research Award 
    [LOI: Jun 21; Application: Sep 6]
  • Ovarian Cancer Academy Award - Early-Career Investigator 
    [LOI: Jun 21; Application: Sep 6]
  • Pilot Award 
    [LOI: Jun 14; Application: Aug 24]
  • Idea Award with Special Focus 
    [LOI: Jun 30; Application: Sep 28]
  • Translational Team Science Award 
    [LOI: Jun 30; Application: Sep 28]

NCCN Breast Cancer Quality Initiative Request for Proposals

Deadline: Jun 26
 
The National Comprehensive Cancer Network (NCCN) is collaborating with Pfizer's Independent Grants for Learning & Change (IGLC) team to offer a new grant opportunity seeking proposals that use clinical pathways to address a quality improvement initiative along the continuum of care for breast cancer patients. 

Lung Cancer Research Foundation

Deadline: Jul 1
 
The Lung Cancer Research Foundation's grant program provides funding for innovative research focused on the prevention, diagnosis, treatment and cure of lung cancer.  
 
Investigators from US and international institutions are eligible to apply for LCRF funding. Individuals must be affiliated with a non-profit academic or research institution and fall into one of the following categories: 
  • Students and fellows
  • Young and mid-career investigators with less than ten years' experience since initial faculty appointment
  • Non-tenure track researchers, staff scientists, and clinicians
Senior investigators with more than ten years' experience since faculty appointment are not eligible for LCRF funding but are encouraged to mentor a junior team member through the application process.

Damon Runyon Innovation Award

Deadline: Jul 6, 2017

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.

The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. 

St. Baldrick's Foundation

LOI Deadline: Jul 7

The St. Baldrick's Foundation announces 2018 Fellowships and the opening of the Fall 2017 infrastructure grant cycle.

Infrastructure Grants: Fall grants are not for a specific research project, but rather for resources to allow more research to be done. They support institutions with the potential for more participation in childhood cancer clinical trials, but which currently lack the necessary resources (primarily support for Clinical Research Associates).

Fellowship Awards:  St. Baldrick's Fellowships are granted for 3rd and 4th, or 4th and 5th years of pediatric oncology research, with an opportunity for one additional year of funding based upon need, significant accomplishment and approved application. 

Request for Proposals for Case CCC Funding for Pilot/Phase I Clinical Trials

Rolling Deadline

The Case CCC is encouraging investigators to submit Letters of Intent (LOI) for Early Phase Clinical Research Support (EPCRS) funding. These in-house funds are available for the conduct of early phase clinical trials of relatively short duration. Priority will be given to trials which are developed jointly between UH and CCF with planned accrual at both institutions.

The proposals are being accepted on a rolling basis subject to availability of funds.

Please direct any questions and/or submit LOIs to Katarzyna Karelus, Case CCC Clinical Research Office, katarzyna.karelus@case.edu, 216.844.4176.

Pancreatic Cancer Action Network - NCI, Frederick National Laboratory for Cancer Research KRAS Travel Scholarship

Rolling Deadline

The Pancreatic Cancer Action Network and NCI Frederick National Laboratory for Cancer Research (FNLCR) have joined together to award KRAS Travel Scholarships to support travel to FNLCR to pursue cutting edge research on pancreatic cancer and KRAS that is aligned with the RAS Initiative. This is a unique and exciting opportunity for researchers to access the intellectual resources and state-of-the-art technology that are available at FNLCR, the only federal national laboratory in the United States devoted exclusively to biomedical research. A total of $25,000 will be awarded in Travel Scholarships on a rolling basis until these funds are committed. The amount of support requested for travel should be consistent with the time needed to accomplish the proposed scope of work at FNLCR. The Scholarship provides reimbursement directly to the Scholar for reasonable and customary travel expenses to and from FNLCR. Expenses eligible for reimbursement include air and ground transportation, parking, hotel and meals.